Company / Current Assets per Share
Edwards Lifesciences Current Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$11.60
FY2025
5-year range
$5.09 / $11.60
FY2021-FY2025
Trend
+11.0%
vs FY2024
Sector context
#84 of 158
Health Care
What the data says
At $11.60, Edwards Lifesciences's current assets per share ranks #84 of 158 in the Health Care sector. Current Assets per Share has increased for 3 consecutive years, from $5.09 in FY2022 to $11.60 in FY2025.
Based on SEC 10-K filings.
11.60 in FY2025 with a 5-year CAGR of +18.6%.
Improved from $6.63 to $11.60 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- +31.6%
- 5-Year CAGR
- +18.6%
- 10-Year CAGR
- -
Sector benchmark
#84 of 158 in Health CareTop 53% of 158This company $11.60 Sector average $54.32
▼
-78.6% below sector average
Key checks
Key Insights
- Edwards Lifesciences's current assets per share has grown for 3 consecutive years.
- In FY2025, current assets per share increased 11.0% year-over-year.
- Ranks #84 out of 158 companies in the Health Care sector.
- Peak current assets per share was recorded in FY2019.
Company context
Key Data Points
- Altman Z-Score 3.16 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $11.60 | +11.0% |
| FY2024 | $10.46 | +57.6% |
| FY2023 | $6.63 | +30.4% |
| FY2022 | $5.09 | -0.1% |
| FY2021 | $5.10 | +2.9% |
| FY2020 | $4.95 | -65.3% |
| FY2019 | $14.27 | +29.6% |
| FY2018 | $11.01 | -8.6% |
| FY2017 | $12.05 | +13.8% |
| FY2016 | $10.59 | -44.3% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026